Kellman P, Hansen MS, Nielles-Vallespin S, Nickander J, Themudo R, Ugander M, et al
Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes
At 4mg: Nausea becomes more common, affecting approximately 20 to 30% of users
Dose adjustments may reach their target level by month three or four, after which most patients plateau their dose unless efficacy warrants further escalation
One medication may be more suitable for people with certain medical conditions or may be a good alternative for people who have tried other weight loss medications and not seen the results they hoped for
Only a case report has described the worsening of psoriasis following the introduction of liraglutide [25]